NCT05105451

Brief Summary

Perioperative neurocognitive disorder (PND) refers to a broad range of postoperative cognitive complications, including preoperatively diagnosed cognitive decline, postoperative delirium (POD), delayed neurocognitive recovery (dNCR), and neurocognitive disorders . Among them, dNCR refers to a decline in cognitive function that occurs approximately 1-4 weeks after anesthesia/surgery in elderly patients. It is associated with an increased risk of postoperative complications and an increased length of hospital stay. The identification of potential predictive biomarkers would be beneficial for determining the individual risk of developing dNCR and for postoperative management of elderly patients. Although some predictive markers for PNDs, such as inflammatory factors, tau protein, S100B protein, neuron-specific enolase, and brain-derived neurotrophic factor, are widely known, most of them are postoperative predictive markers. The markers that can be used to predict PNDs before anesthesia/surgery are still largely unknown. Preoperative markers allow us to identify individuals who are susceptible to dNCR and intervene early. It is unclear whether the metabolic status of preoperative patients is related to the occurrence of postoperative cognitive dysfunction (POCD). In the framework of systems biology based on genome, transcriptome, proteome, and metabolome, metabolomics is the closest to biological phenotypes because it reflects biological events that have occurred in living organisms. Considering that metabolome reflects the metabolites of all biochemical reactions that have already taken place in an organism and contains a huge amount of information about an organism's health, preoperative patient metabolites may be a useful predictive biomarker. In this study, we used serum metabolomics to develop non-invasive, easily detectable, and inexpensive preoperative biomarkers from patient blood to determine the individual risk of dNCR and the relationship between metabolic system abnormalities and the pathogenesis of dNCR.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
8mo left

Started May 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
May 2021Dec 2026

Study Start

First participant enrolled

May 22, 2021

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

May 28, 2021

Completed
5 months until next milestone

First Posted

Study publicly available on registry

November 3, 2021

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

July 18, 2023

Status Verified

July 1, 2023

Enrollment Period

5.6 years

First QC Date

May 28, 2021

Last Update Submit

July 16, 2023

Conditions

Outcome Measures

Primary Outcomes (10)

  • MMSE (mini-mental state examiniation)

    MMSE scale score, If the MMSE assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of dNCR.

    1 day after surgery

  • MOCA (Montreal Cognitive Assessment)

    MOCA sacle score, If the MOCA assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of dNCR.

    1 day after surgery

  • MMSE (mini-mental state examiniation)

    MMSE scale score, If the MMSE assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of dNCR.a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of dNCR.

    3 day after surgery

  • MOCA (Montreal Cognitive Assessment)

    MOCA sacle score, If the MOCA assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of dNCR.

    3 day after surgery

  • MMSE (mini-mental state examiniation)

    MMSE scale score, If the MMSE assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of dNCR. a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of dNCR.

    7 day after surgery

  • MOCA (Montreal Cognitive Assessment)

    MOCA sacle score, If the MOCA assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of dNCR.

    7 day after surgery

  • MOCA (Montreal Cognitive Assessment)

    MOCA sacle score,baseline

    right before surgery

  • MMSE (mini-mental state examiniation)

    MMSE scale score, baseline

    right before surgery

  • T-MoCA (The telephone MoCA)

    MOCA sacle score, If the MOCA assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of dNCR.

    15 day after surgery

  • T-MoCA (The telephone MoCA)

    MOCA sacle score, If the MOCA assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of dNCR.

    30 day after surgery

Secondary Outcomes (3)

  • 3D-CAM

    1 day after surgery

  • Self-Rating Anxiety Scale

    right before surgery

  • Self-rating depression scale

    right before surgery

Study Arms (2)

Patients in the control group were followed up without dNCR postoperatively.

If the MOCA or MMSE assessment all show a negative resluts at all time point.

Other: Collecting clinical data, EGG,arterial blood gas data and venous blood sample

Patients in the case group were followed up with dNCR postoperatively.

If the MOCA assessment is positive at any time point after surgery, and there is a positive MMSE at any time point after surgery(no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of dNCR.

Other: Collecting clinical data, EGG,arterial blood gas data and venous blood sample

Interventions

Collecting clinical data(before induction of anesthesia and first day after surgery), EGG(first day after surgery),arterial blood gas data(before induction of anesthesia and first day after surgery) and venous blood sample (before induction of anesthesia and first day, third day and 7th day after surgery)

Patients in the case group were followed up with dNCR postoperatively.Patients in the control group were followed up without dNCR postoperatively.

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Our research is a single center, nested case-control study. Preoperatively collect the information of the elderly patients over 65 years old without undergoing craniocerebral operations, including the vital signs, the examination reports and other related data after excluding the factors that can't be included in the group. The patients' health scales and dNCR. scales were evaluated.

You may qualify if:

  • Gender: no gender limit
  • years or older .
  • Complete the operation in our hospital
  • ASA classification I-II level
  • Agree to participate in this research and agree to sign an informed consent form

You may not qualify if:

  • History of preoperative psychosis and psychotropic drug use
  • The subject is diagnosed with AD;
  • Abnormal preoperative mental scale assessment
  • Have a history of emergency rescue during the perioperative period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai 9Th Hospital

Shanghai, Shanghai Municipality, 200000, China

Location

Related Publications (2)

  • Zhang L, Liu J, Zhou R, Liu J, Zhang J, Mao H, Yan J, Jiang H. Preoperative tyrosine is associated with postoperative delayed neurocognitive recovery in elderly: Evidence from two hospitals. Clin Nutr ESPEN. 2025 Aug;68:727-736. doi: 10.1016/j.clnesp.2025.06.016. Epub 2025 Jun 13.

  • Mao H, Huang H, Zhou R, Zhu J, Yan J, Jiang H, Zhang L. High preoperative blood oxaloacetate and 2-aminoadipic acid levels are associated with postoperative delayed neurocognitive recovery. Front Endocrinol (Lausanne). 2023 Jul 31;14:1212815. doi: 10.3389/fendo.2023.1212815. eCollection 2023.

Biospecimen

Retention: SAMPLES WITH DNA

whole blood

Study Officials

  • Hong Jiang, Doctor

    Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 28, 2021

First Posted

November 3, 2021

Study Start

May 22, 2021

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

July 18, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations